Value
- Base
- 13.00
- Cagr
- 18.06
- Currency
- USD
- Forecast
- 49.70
- Unit
- Billion
Graph-backed node
The global nuclear medicine market is poised for substantial growth, with a base year market size of USD 13.00 billion in 2025. The market is forecasted to expand at a robust compound annual growth rate (CAGR) of 18.06375% during the period from 2026 to 2030, resulting in an anticipated market size of USD 29.82 billion by the end of the forecast period.
The global nuclear medicine market is poised for substantial growth, with a base year market size of USD 13.00 billion in 2025. The market is forecasted to expand at a robust compound annual growth rate (CAGR) of 18.06375% during the period from 2026 to 2030, resulting in an anticipated market size of USD 29.82 billion by the end of the forecast period.
The global nuclear medicine market is anticipated to reach USD 29.82 billion by the end of the forecast period in 2030
The nuclear medicine market is forecasted to expand at a CAGR of 18.06375% during the period from 2026 to 2030.
Technological advancements, including positron emission tomography (PET) and single-photon emission computed tomography (SPECT), are key drivers of growth in the nuclear medicine market.
Key players in the global nuclear medicine market include Life Healthcare, Bayer AG, NorthStar Medical Radioisotopes, LLC, GE Healthcare, and Lantheus Holdings, Inc.,
Environment: live
Freshness: 2026-06-12T19:44:36+00:00
Resolved node: MIMR-node_fc7374c
Statsfocus
https://statsfocus.com
Knowledge graph of market intelligence